Ugandan pharmaceutical firm Cipla Quality Chemicals shares have gone up 17.8 percent, to an average of Ush112 (0.030) per unit in the first three weeks of January, from Ush95 ($0.025) in July-August 2020.
Investment advisors attribute the rise of the share price to the drug maker’s remodelling of its business and planned discount of the Zambia debt.
